BioAge Labs BIOA
NASDAQ BIOA
$9.17 -0.23 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) Treasury Shares (2023 - 2024)

BioAge Labs' (BIOA) quarterly Treasury Shares came in at $93.1 million in Q2 2024, little changed quarter-over-quarter from $93.1 million in Q1 2024.

Analysis

BioAge Labs (BIOA) Treasury Shares (2023 - 2024) Analysis & Trends

BioAge Labs has disclosed Treasury Shares across 2 years of filings, most recently posting $93.1 million for Q2 2024.

  • In Q2 2024, Treasury Shares changed N/A year-over-year to $93.1 million; the TTM figure through Jun 2024 stood at $93.1 million (changed N/A YoY), while the FY2023 annual figure was $31.5 million, changed N/A from the prior year.
  • Treasury Shares came in at $93.1 million for Q2 2024 at BioAge Labs, roughly flat from $93.1 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $93.1 million in Q1 2024 to a low of $31.5 million in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -23.80 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 BioAge Labs 439.00 Mn 439.00 Mn -14.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 93.07 Mn
Jun 30, 2024 93.07 Mn
Mar 31, 2024 93.07 Mn
Mar 31, 2024 93.07 Mn
Dec 31, 2023 31.47 Mn
Dec 31, 2023 31.47 Mn
Sep 30, 2023 31.47 Mn
Sep 30, 2023 31.47 Mn